How High Will Take-Two Stock Go?
Take-Two Interactive (NASDAQ:TTWO) is the video game development company behind…
Sell
47
DK Quote, Financials, Valuation and Earnings
Last price:
$21.74
Seasonality move
:
0.85%
Day range:
$21.26 - $21.82
52-week range:
$11.03 - $25.68
Dividend yield:
4.69%
P/E ratio:
--
P/S ratio:
0.12x
P/B ratio:
8.51x
Volume:
2.4M
Avg. volume:
1.8M
1-year change:
-10.41%
Market cap:
$1.3B
Revenue:
$11.9B
EPS (TTM):
-$11.11
Analysts' Opinion
-
Consensus RatingDelek US Holdings has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 7 Hold ratings, and 3 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $16.40, Delek US Holdings has an estimated downside of -24.65% from its current price of $21.77.
-
Price Target UpsideAccording to analysts, the highest upside price target is $23.00 representing -100% upside increase from its current price of $21.77.
Fair Value
-
According to the consensus of 12 analysts, Delek US Holdings has -24.65% downside to fair value with a price target of $16.40 per share.
DK vs. S&P 500
-
Over the past 5 trading days, Delek US Holdings has overperformed the S&P 500 by 7.88% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Delek US Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Delek US Holdings revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Delek US Holdings reported revenues of $2.6B.
Earnings Growth
-
Delek US Holdings has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Delek US Holdings reported earnings per share of -$2.78.
Enterprise value:
4B
EV / Invested capital:
--
Price / LTM sales:
0.12x
EV / EBIT:
13.41x
EV / Revenue:
0.35x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-4.84x
Price / Operating cash flow:
3.64x
Enterprise value / EBITDA:
10.38x
Gross Profit (TTM):
-$191.5M
Return On Assets:
-10.09%
Net Income Margin (TTM):
-6.1%
Return On Equity:
-88.27%
Return On Invested Capital:
-20%
Operating Margin:
-4.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $19.3B | $15.9B | $11.5B | $3.1B | $2.6B | |
| Gross Profit | $871.1M | $464.8M | -$191.5M | $89.6M | -$70M | |
| Operating Income | $522.4M | $165.1M | -$414.7M | $29.2M | -$125.8M | |
| EBITDA | $915.9M | $586M | -$162.6M | $143.4M | -$9.6M | |
| Diluted EPS | $4.37 | -$1.24 | -$11.11 | -$0.51 | -$2.78 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.9B | $4.2B | $3.2B | $2.7B | $2.2B | |
| Total Assets | $6.7B | $7.9B | $7.8B | $7.2B | $6.9B | |
| Current Liabilities | $2.5B | $4.3B | $2.9B | $2.6B | $2.6B | |
| Total Liabilities | $5.7B | $7B | $6.7B | $6.1B | $6.5B | |
| Total Equity | $1B | $974.7M | $1.1B | $1B | $429.4M | |
| Total Debt | $2.4B | $2.2B | $2.8B | $2.5B | $3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $793.6M | $785.2M | -$295.9M | $166.7M | -$62.4M | |
| Cash From Investing | -$1.1B | -$227.5M | -$514.5M | -$41.6M | -$314.6M | |
| Cash From Financing | $340.8M | -$669.3M | $680.8M | -$193.9M | $265.2M | |
| Free Cash Flow | $327.8M | $561.3M | -$827.8M | $127.7M | -$202.7M | |
DK
Sector
Market Cap
$1.3B
$62.8M
Price % of 52-Week High
84.77%
67.77%
Dividend Yield
4.69%
0%
Shareholder Yield
-27.41%
4.7%
1-Year Price Total Return
-10.41%
-18.59%
Beta (5-Year)
0.967
0.652
Dividend yield:
4.69%
Annualized payout:
$1.01
Payout ratio:
-9.19%
Growth streak:
2 years
Technicals
8-day SMA
Buy
Level
$21.07
200-day SMA
Buy
Level
$17.52
Bollinger Bands (100)
Buy
Level
13.9 - 19.26
Chaikin Money Flow
Buy
Level
8.1M
20-day SMA
Buy
Level
$19.98
Relative Strength Index (RSI14)
Buy
Level
65.96
ADX Line
Buy
Level
38.15
Williams %R
Neutral
Level
-25.2049
50-day SMA
Buy
Level
$16.72
MACD (12, 26)
Buy
Level
1.42
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Neutral
Level
28.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6212)
Sell
CA Score
(Annual)
Level (-1.9591)
Buy
Beneish M-Score
(Annual)
Level (-6.7059)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (2.2592)
Sell
Piotroski F Score
(Annual)
Level (2)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.
Stock Forecast FAQ
In the current month, DK has received 2 Buy ratings 7 Hold ratings, and 3 Sell ratings. The DK average analyst price target in the past 3 months is $16.40.
-
Where Will Delek US Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Delek US Holdings share price will drop to $16.40 per share over the next 12 months.
-
What Do Analysts Say About Delek US Holdings?
Analysts are divided on their view about Delek US Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Delek US Holdings is a Buy and believe this share price will rise from its current level to $23.00.
-
What Is Delek US Holdings's Price Target?
The price target for Delek US Holdings over the next 1-year time period is forecast to be $16.40 according to 12 Wall Street analysts, 2 of them rate the stock a Buy, 3 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is DK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Delek US Holdings is a Hold. 7 of 12 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of DK?
You can purchase shares of Delek US Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Delek US Holdings shares.
-
What Is The Delek US Holdings Share Price Today?
Delek US Holdings was last trading at $21.74 per share. This represents the most recent stock quote for Delek US Holdings. Yesterday, Delek US Holdings closed at $21.77 per share.
-
How To Buy Delek US Holdings Stock Online?
In order to purchase Delek US Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Target’s Stock Be in 10 Years?
If you could hop into a time machine and land…
Why Did Stan Druckenmiller Buy DocuSign?
Billionaire Stanley Druckenmiller’s Duquesne Family Office portfolio is always worth…
Stock Ideas
Buy
64
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
37
RGC alert for Jun 21
Regencell Bioscience Holdings [RGC] is down 40.02% over the past day.
Buy
83
GMS alert for Jun 21
GMS [GMS] is up 23.79% over the past day.
Buy
57
QNTM alert for Jun 21
Quantum BioPharma [QNTM] is up 13.82% over the past day.
